Frontiers in Pharmacology
SGLT2 inhibitors, semaglutide, and finerenone in diabetic kidney disease: a Bayesian network meta-analysis
Meta-analysis of randomised trialsSGLT2 inhibitors
Papers by Xiangmei Chen
5 results
- European Heart Journal
Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis
Trial in peopleInterventions
- ADA Scientific Sessions 2025 Abstract
Mazdutide, a Dual GLP-1R/GCGR Agonist, Reduces Hyperuricemia by Modulating Energy and Lipid Metabolism and Inhibiting Hepatic Purine Metabolism
Experiments in animalsInterventions